nodes	percent_of_prediction	percent_of_DWPC	metapath
Methyl aminolevulinate—FCGR1A—FCGR activation—FCGR2A—ulcerative colitis	0.0524	0.105	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Role of phospholipids in phagocytosis—FCGR2A—ulcerative colitis	0.031	0.062	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Regulation of actin dynamics for phagocytic cup formation—ARPC2—ulcerative colitis	0.0302	0.0603	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Fcgamma receptor (FCGR) dependent phagocytosis—ARPC2—ulcerative colitis	0.0228	0.0455	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Regulation of actin dynamics for phagocytic cup formation—FCGR2A—ulcerative colitis	0.016	0.0321	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Interferon gamma signaling—IRF5—ulcerative colitis	0.0151	0.0302	CbGpPWpGaD
Methyl aminolevulinate—Scab—Budesonide—ulcerative colitis	0.015	0.0301	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Interferon gamma signaling—IRF8—ulcerative colitis	0.0144	0.0289	CbGpPWpGaD
Methyl aminolevulinate—Vitreous detachment—Dexamethasone—ulcerative colitis	0.0144	0.0288	CcSEcCtD
Methyl aminolevulinate—Vitreous detachment—Betamethasone—ulcerative colitis	0.0144	0.0288	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Interferon gamma signaling—PTPN2—ulcerative colitis	0.0132	0.0264	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Fcgamma receptor (FCGR) dependent phagocytosis—FCGR2A—ulcerative colitis	0.0121	0.0242	CbGpPWpGaD
Methyl aminolevulinate—Skin hyperpigmentation—Mercaptopurine—ulcerative colitis	0.012	0.0241	CcSEcCtD
Methyl aminolevulinate—Skin burning sensation—Hydrocortisone—ulcerative colitis	0.0113	0.0227	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Class I MHC mediated antigen processing & presentation—HERC2—ulcerative colitis	0.0112	0.0223	CbGpPWpGaD
Methyl aminolevulinate—Burning sensation—Nicotine—ulcerative colitis	0.00999	0.02	CcSEcCtD
Methyl aminolevulinate—Localized exfoliation—Triamcinolone—ulcerative colitis	0.00966	0.0193	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Interferon gamma signaling—VCAM1—ulcerative colitis	0.00966	0.0193	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Interferon gamma signaling—HLA-DQA1—ulcerative colitis	0.00963	0.0193	CbGpPWpGaD
Methyl aminolevulinate—Blister—Nicotine—ulcerative colitis	0.00963	0.0193	CcSEcCtD
Methyl aminolevulinate—Skin infection—Hydrocortisone—ulcerative colitis	0.00915	0.0183	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Cytokine Signaling in Immune system—IL1R2—ulcerative colitis	0.0082	0.0164	CbGpPWpGaD
Methyl aminolevulinate—Eye irritation—Nicotine—ulcerative colitis	0.00813	0.0163	CcSEcCtD
Methyl aminolevulinate—Allergic contact dermatitis—Hydrocortisone—ulcerative colitis	0.00791	0.0158	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Innate Immune System—DEFA6—ulcerative colitis	0.00759	0.0152	CbGpPWpGaD
Methyl aminolevulinate—Ulcer—Mercaptopurine—ulcerative colitis	0.00757	0.0152	CcSEcCtD
Methyl aminolevulinate—Allergic contact dermatitis—Triamcinolone—ulcerative colitis	0.00745	0.0149	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Interferon Signaling—IRF5—ulcerative colitis	0.00738	0.0147	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Interferon Signaling—IRF8—ulcerative colitis	0.00705	0.0141	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Cytokine Signaling in Immune system—IL7R—ulcerative colitis	0.00697	0.0139	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Interferon gamma signaling—HLA-DRB1—ulcerative colitis	0.00685	0.0137	CbGpPWpGaD
Methyl aminolevulinate—Allergic contact dermatitis—Dexamethasone—ulcerative colitis	0.00676	0.0135	CcSEcCtD
Methyl aminolevulinate—Allergic contact dermatitis—Betamethasone—ulcerative colitis	0.00676	0.0135	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Interferon gamma signaling—ICAM1—ulcerative colitis	0.00658	0.0131	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Interferon Signaling—PTPN2—ulcerative colitis	0.00645	0.0129	CbGpPWpGaD
Methyl aminolevulinate—Rash pustular—Budesonide—ulcerative colitis	0.00599	0.012	CcSEcCtD
Methyl aminolevulinate—Burning sensation—Mesalazine—ulcerative colitis	0.00559	0.0112	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—HERC2—ulcerative colitis	0.00552	0.011	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Innate Immune System—MASP2—ulcerative colitis	0.00549	0.011	CbGpPWpGaD
Methyl aminolevulinate—Blister—Mesalazine—ulcerative colitis	0.00539	0.0108	CcSEcCtD
Methyl aminolevulinate—Dermatitis bullous—Nicotine—ulcerative colitis	0.00527	0.0105	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—ICOSLG—ulcerative colitis	0.00527	0.0105	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Interferon gamma signaling—JAK2—ulcerative colitis	0.0051	0.0102	CbGpPWpGaD
Methyl aminolevulinate—Ulcer—Budesonide—ulcerative colitis	0.00505	0.0101	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Interferon gamma signaling—IFNG—ulcerative colitis	0.005	0.01	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Cytokine Signaling in Immune system—IRF5—ulcerative colitis	0.00493	0.00985	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Innate Immune System—DEFA5—ulcerative colitis	0.00489	0.00977	CbGpPWpGaD
Methyl aminolevulinate—Rash pustular—Mesalazine—ulcerative colitis	0.00487	0.00975	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Innate Immune System—ARPC2—ulcerative colitis	0.00473	0.00946	CbGpPWpGaD
Methyl aminolevulinate—Dermatitis contact—Budesonide—ulcerative colitis	0.00472	0.00945	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Interferon Signaling—VCAM1—ulcerative colitis	0.00472	0.00943	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Cytokine Signaling in Immune system—IRF8—ulcerative colitis	0.00471	0.00941	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Interferon Signaling—HLA-DQA1—ulcerative colitis	0.0047	0.0094	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—TNFRSF14—ulcerative colitis	0.00469	0.00938	CbGpPWpGaD
Methyl aminolevulinate—Skin hyperpigmentation—Hydrocortisone—ulcerative colitis	0.00465	0.0093	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Immune System—DEFA6—ulcerative colitis	0.00442	0.00883	CbGpPWpGaD
Methyl aminolevulinate—Skin hyperpigmentation—Triamcinolone—ulcerative colitis	0.00437	0.00876	CcSEcCtD
Methyl aminolevulinate—Skin hyperpigmentation—Methylprednisolone—ulcerative colitis	0.00437	0.00874	CcSEcCtD
Methyl aminolevulinate—Keratitis—Prednisolone—ulcerative colitis	0.00436	0.00873	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Cytokine Signaling in Immune system—PTPN2—ulcerative colitis	0.00431	0.00861	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Innate Immune System—CARD9—ulcerative colitis	0.00399	0.00797	CbGpPWpGaD
Methyl aminolevulinate—Skin hyperpigmentation—Betamethasone—ulcerative colitis	0.00397	0.00794	CcSEcCtD
Methyl aminolevulinate—Skin hyperpigmentation—Dexamethasone—ulcerative colitis	0.00397	0.00794	CcSEcCtD
Methyl aminolevulinate—Swelling—Budesonide—ulcerative colitis	0.00393	0.00787	CcSEcCtD
Methyl aminolevulinate—Blister—Prednisolone—ulcerative colitis	0.00393	0.00786	CcSEcCtD
Methyl aminolevulinate—Eczema—Budesonide—ulcerative colitis	0.00386	0.00772	CcSEcCtD
Methyl aminolevulinate—Skin exfoliation—Mesalazine—ulcerative colitis	0.00371	0.00743	CcSEcCtD
Methyl aminolevulinate—Keratitis—Betamethasone—ulcerative colitis	0.00364	0.00729	CcSEcCtD
Methyl aminolevulinate—Keratitis—Dexamethasone—ulcerative colitis	0.00364	0.00729	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Cytokine Signaling in Immune system—RIPK2—ulcerative colitis	0.00362	0.00724	CbGpPWpGaD
Methyl aminolevulinate—Blister—Triamcinolone—ulcerative colitis	0.00361	0.00722	CcSEcCtD
Methyl aminolevulinate—Stinging—Prednisolone—ulcerative colitis	0.00349	0.00699	CcSEcCtD
Methyl aminolevulinate—Stinging—Hydrocortisone—ulcerative colitis	0.00341	0.00683	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Immune System—HERC2—ulcerative colitis	0.00335	0.00669	CbGpPWpGaD
Methyl aminolevulinate—Face oedema—Budesonide—ulcerative colitis	0.00335	0.0067	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Interferon Signaling—HLA-DRB1—ulcerative colitis	0.00335	0.00669	CbGpPWpGaD
Methyl aminolevulinate—Eye irritation—Prednisolone—ulcerative colitis	0.00331	0.00663	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Cytokine Signaling in Immune system—NOD2—ulcerative colitis	0.00328	0.00656	CbGpPWpGaD
Methyl aminolevulinate—Blister—Dexamethasone—ulcerative colitis	0.00328	0.00656	CcSEcCtD
Methyl aminolevulinate—Blister—Betamethasone—ulcerative colitis	0.00328	0.00656	CcSEcCtD
Methyl aminolevulinate—Stinging—Triamcinolone—ulcerative colitis	0.00321	0.00643	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Interferon Signaling—ICAM1—ulcerative colitis	0.00321	0.00642	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—MASP2—ulcerative colitis	0.00319	0.00639	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—ICOSLG—ulcerative colitis	0.00319	0.00639	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Cytokine Signaling in Immune system—VCAM1—ulcerative colitis	0.00315	0.00629	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Cytokine Signaling in Immune system—HLA-DQA1—ulcerative colitis	0.00314	0.00628	CbGpPWpGaD
Methyl aminolevulinate—Eczema—Mesalazine—ulcerative colitis	0.00314	0.00628	CcSEcCtD
Methyl aminolevulinate—Eye pain—Mesalazine—ulcerative colitis	0.00312	0.00625	CcSEcCtD
Methyl aminolevulinate—Erythema—Nicotine—ulcerative colitis	0.00303	0.00607	CcSEcCtD
Methyl aminolevulinate—Dermatitis bullous—Mesalazine—ulcerative colitis	0.00295	0.00591	CcSEcCtD
Methyl aminolevulinate—Stinging—Dexamethasone—ulcerative colitis	0.00291	0.00583	CcSEcCtD
Methyl aminolevulinate—Stinging—Betamethasone—ulcerative colitis	0.00291	0.00583	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Immune System—TNFRSF14—ulcerative colitis	0.00285	0.00569	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—DEFA5—ulcerative colitis	0.00285	0.00569	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—ITGAL—ulcerative colitis	0.00279	0.00558	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—ARPC2—ulcerative colitis	0.00276	0.00551	CbGpPWpGaD
Methyl aminolevulinate—Ulcer—Triamcinolone—ulcerative colitis	0.00275	0.00551	CcSEcCtD
Methyl aminolevulinate—Dermatitis contact—Hydrocortisone—ulcerative colitis	0.00273	0.00547	CcSEcCtD
Methyl aminolevulinate—Face oedema—Mesalazine—ulcerative colitis	0.00272	0.00545	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Immune System—IL1R2—ulcerative colitis	0.00268	0.00535	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Innate Immune System—CCR6—ulcerative colitis	0.00264	0.00528	CbGpPWpGaD
Methyl aminolevulinate—Skin exfoliation—Hydrocortisone—ulcerative colitis	0.00264	0.00528	CcSEcCtD
Methyl aminolevulinate—Dermatitis contact—Triamcinolone—ulcerative colitis	0.00257	0.00515	CcSEcCtD
Methyl aminolevulinate—Oedema—Mercaptopurine—ulcerative colitis	0.00255	0.00511	CcSEcCtD
Methyl aminolevulinate—Discomfort—Nicotine—ulcerative colitis	0.00255	0.00511	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Innate Immune System—FCGR2A—ulcerative colitis	0.00252	0.00503	CbGpPWpGaD
Methyl aminolevulinate—Ulcer—Dexamethasone—ulcerative colitis	0.0025	0.005	CcSEcCtD
Methyl aminolevulinate—Ulcer—Betamethasone—ulcerative colitis	0.0025	0.005	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Interferon Signaling—JAK2—ulcerative colitis	0.00249	0.00498	CbGpPWpGaD
Methyl aminolevulinate—Skin exfoliation—Triamcinolone—ulcerative colitis	0.00248	0.00497	CcSEcCtD
Methyl aminolevulinate—Skin exfoliation—Methylprednisolone—ulcerative colitis	0.00248	0.00496	CcSEcCtD
Methyl aminolevulinate—Oedema—Nicotine—ulcerative colitis	0.00248	0.00495	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Interferon Signaling—IFNG—ulcerative colitis	0.00244	0.00488	CbGpPWpGaD
Methyl aminolevulinate—Dermatitis contact—Betamethasone—ulcerative colitis	0.00233	0.00467	CcSEcCtD
Methyl aminolevulinate—Dermatitis contact—Dexamethasone—ulcerative colitis	0.00233	0.00467	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Immune System—CARD9—ulcerative colitis	0.00232	0.00464	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—IL7R—ulcerative colitis	0.00228	0.00455	CbGpPWpGaD
Methyl aminolevulinate—Skin exfoliation—Betamethasone—ulcerative colitis	0.00225	0.00451	CcSEcCtD
Methyl aminolevulinate—Skin exfoliation—Dexamethasone—ulcerative colitis	0.00225	0.00451	CcSEcCtD
Methyl aminolevulinate—Eye disorder—Budesonide—ulcerative colitis	0.00224	0.00449	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Cytokine Signaling in Immune system—HLA-DRB1—ulcerative colitis	0.00223	0.00447	CbGpPWpGaD
Methyl aminolevulinate—Eczema—Hydrocortisone—ulcerative colitis	0.00223	0.00447	CcSEcCtD
Methyl aminolevulinate—Photosensitivity reaction—Mesalazine—ulcerative colitis	0.00223	0.00445	CcSEcCtD
Methyl aminolevulinate—Paraesthesia—Nicotine—ulcerative colitis	0.00222	0.00445	CcSEcCtD
Methyl aminolevulinate—Ulcer—Prednisone—ulcerative colitis	0.00217	0.00435	CcSEcCtD
Methyl aminolevulinate—Dermatitis bullous—Prednisolone—ulcerative colitis	0.00215	0.0043	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Cytokine Signaling in Immune system—ICAM1—ulcerative colitis	0.00214	0.00429	CbGpPWpGaD
Methyl aminolevulinate—Fatigue—Nicotine—ulcerative colitis	0.00213	0.00427	CcSEcCtD
Methyl aminolevulinate—Pain—Nicotine—ulcerative colitis	0.00212	0.00424	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Innate Immune System—CALM3—ulcerative colitis	0.00206	0.00412	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Innate Immune System—RIPK2—ulcerative colitis	0.00203	0.00406	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—CALM3—ulcerative colitis	0.00198	0.00396	CbGpPWpGaD
Methyl aminolevulinate—Dermatitis bullous—Triamcinolone—ulcerative colitis	0.00198	0.00396	CcSEcCtD
Methyl aminolevulinate—Urticaria—Nicotine—ulcerative colitis	0.00197	0.00394	CcSEcCtD
Methyl aminolevulinate—Skin exfoliation—Prednisone—ulcerative colitis	0.00196	0.00393	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—RIPK2—ulcerative colitis	0.00195	0.0039	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—CTLA4—ulcerative colitis	0.00192	0.00384	CbGpPWpGaD
Methyl aminolevulinate—Eye pain—Betamethasone—ulcerative colitis	0.0019	0.0038	CcSEcCtD
Methyl aminolevulinate—Eye pain—Dexamethasone—ulcerative colitis	0.0019	0.0038	CcSEcCtD
Methyl aminolevulinate—Hypersensitivity—Mercaptopurine—ulcerative colitis	0.00188	0.00377	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Innate Immune System—NOD2—ulcerative colitis	0.00184	0.00368	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—CD79A—ulcerative colitis	0.00183	0.00366	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Innate Immune System—CD14—ulcerative colitis	0.00183	0.00366	CbGpPWpGaD
Methyl aminolevulinate—Hypersensitivity—Nicotine—ulcerative colitis	0.00182	0.00365	CcSEcCtD
Methyl aminolevulinate—Eye disorder—Mesalazine—ulcerative colitis	0.00182	0.00365	CcSEcCtD
Methyl aminolevulinate—Dermatitis bullous—Betamethasone—ulcerative colitis	0.00179	0.00359	CcSEcCtD
Methyl aminolevulinate—Dermatitis bullous—Dexamethasone—ulcerative colitis	0.00179	0.00359	CcSEcCtD
Methyl aminolevulinate—Asthenia—Nicotine—ulcerative colitis	0.00178	0.00355	CcSEcCtD
Methyl aminolevulinate—Discomfort—Budesonide—ulcerative colitis	0.00176	0.00352	CcSEcCtD
Methyl aminolevulinate—Pruritus—Nicotine—ulcerative colitis	0.00175	0.00351	CcSEcCtD
Methyl aminolevulinate—Erythema—Mesalazine—ulcerative colitis	0.0017	0.0034	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—VCAM1—ulcerative colitis	0.0017	0.00339	CbGpPWpGaD
Methyl aminolevulinate—Infection—Budesonide—ulcerative colitis	0.00169	0.00339	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Immune System—ITGAL—ulcerative colitis	0.00169	0.00338	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—HLA-DQA1—ulcerative colitis	0.00169	0.00338	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Cytokine Signaling in Immune system—JAK2—ulcerative colitis	0.00166	0.00332	CbGpPWpGaD
Methyl aminolevulinate—Dizziness—Nicotine—ulcerative colitis	0.00164	0.00328	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Cytokine Signaling in Immune system—IFNG—ulcerative colitis	0.00163	0.00326	CbGpPWpGaD
Methyl aminolevulinate—Rash—Mercaptopurine—ulcerative colitis	0.00161	0.00322	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Cytokine Signaling in Immune system—RELA—ulcerative colitis	0.00161	0.00322	CbGpPWpGaD
Methyl aminolevulinate—Dermatitis—Mercaptopurine—ulcerative colitis	0.00161	0.00322	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Immune System—IRF5—ulcerative colitis	0.00161	0.00322	CbGpPWpGaD
Methyl aminolevulinate—Discomfort—Azathioprine—ulcerative colitis	0.00157	0.00314	CcSEcCtD
Methyl aminolevulinate—Rash—Nicotine—ulcerative colitis	0.00156	0.00312	CcSEcCtD
Methyl aminolevulinate—Dermatitis—Nicotine—ulcerative colitis	0.00156	0.00312	CcSEcCtD
Methyl aminolevulinate—Headache—Nicotine—ulcerative colitis	0.00155	0.0031	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Immune System—IRF8—ulcerative colitis	0.00154	0.00307	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—CCR6—ulcerative colitis	0.00154	0.00307	CbGpPWpGaD
Methyl aminolevulinate—Paraesthesia—Budesonide—ulcerative colitis	0.00153	0.00306	CcSEcCtD
Methyl aminolevulinate—Nausea—Mercaptopurine—ulcerative colitis	0.00152	0.00304	CcSEcCtD
Methyl aminolevulinate—Infection—Azathioprine—ulcerative colitis	0.00151	0.00303	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Innate Immune System—ADCY5—ulcerative colitis	0.0015	0.00299	CbGpPWpGaD
Methyl aminolevulinate—Nausea—Nicotine—ulcerative colitis	0.00147	0.00294	CcSEcCtD
Methyl aminolevulinate—Fatigue—Budesonide—ulcerative colitis	0.00147	0.00294	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Immune System—FCGR2A—ulcerative colitis	0.00147	0.00293	CbGpPWpGaD
Methyl aminolevulinate—Pain—Budesonide—ulcerative colitis	0.00146	0.00292	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Cytokine Signaling in Immune system—IL1B—ulcerative colitis	0.00146	0.00291	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Cytokine Signaling in Immune system—IL2—ulcerative colitis	0.00145	0.0029	CbGpPWpGaD
Methyl aminolevulinate—Face oedema—Prednisone—ulcerative colitis	0.00144	0.00288	CcSEcCtD
Methyl aminolevulinate—Discomfort—Mesalazine—ulcerative colitis	0.00143	0.00286	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Immune System—PTPN2—ulcerative colitis	0.00141	0.00281	CbGpPWpGaD
Methyl aminolevulinate—Oedema—Mesalazine—ulcerative colitis	0.00139	0.00277	CcSEcCtD
Methyl aminolevulinate—Infection—Mesalazine—ulcerative colitis	0.00138	0.00276	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Cytokine Signaling in Immune system—NFKB1—ulcerative colitis	0.00136	0.00271	CbGpPWpGaD
Methyl aminolevulinate—Urticaria—Budesonide—ulcerative colitis	0.00135	0.00271	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Innate Immune System—CRP—ulcerative colitis	0.00131	0.00261	CbGpPWpGaD
Methyl aminolevulinate—Eye disorder—Hydrocortisone—ulcerative colitis	0.0013	0.0026	CcSEcCtD
Methyl aminolevulinate—Hypersensitivity—Budesonide—ulcerative colitis	0.00126	0.00251	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Innate Immune System—TLR4—ulcerative colitis	0.00125	0.00251	CbGpPWpGaD
Methyl aminolevulinate—Paraesthesia—Mesalazine—ulcerative colitis	0.00125	0.00249	CcSEcCtD
Methyl aminolevulinate—Erythema—Prednisolone—ulcerative colitis	0.00124	0.00248	CcSEcCtD
Methyl aminolevulinate—Asthenia—Budesonide—ulcerative colitis	0.00122	0.00245	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Cytokine Signaling in Immune system—STAT3—ulcerative colitis	0.00122	0.00244	CbGpPWpGaD
Methyl aminolevulinate—Eye disorder—Methylprednisolone—ulcerative colitis	0.00122	0.00244	CcSEcCtD
Methyl aminolevulinate—Erythema—Hydrocortisone—ulcerative colitis	0.00121	0.00242	CcSEcCtD
Methyl aminolevulinate—Pruritus—Budesonide—ulcerative colitis	0.00121	0.00241	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—HLA-DRB1—ulcerative colitis	0.0012	0.0024	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—CALM3—ulcerative colitis	0.0012	0.0024	CbGpPWpGaD
Methyl aminolevulinate—Fatigue—Mesalazine—ulcerative colitis	0.0012	0.00239	CcSEcCtD
Methyl aminolevulinate—Pain—Mesalazine—ulcerative colitis	0.00119	0.00237	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Immune System—RIPK2—ulcerative colitis	0.00118	0.00236	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—CTLA4—ulcerative colitis	0.00117	0.00233	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—ICAM1—ulcerative colitis	0.00115	0.00231	CbGpPWpGaD
Methyl aminolevulinate—Erythema—Triamcinolone—ulcerative colitis	0.00114	0.00228	CcSEcCtD
Methyl aminolevulinate—Erythema—Methylprednisolone—ulcerative colitis	0.00114	0.00227	CcSEcCtD
Methyl aminolevulinate—Dizziness—Budesonide—ulcerative colitis	0.00113	0.00226	CcSEcCtD
Methyl aminolevulinate—Hypersensitivity—Azathioprine—ulcerative colitis	0.00112	0.00224	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Immune System—CD79A—ulcerative colitis	0.00111	0.00222	CbGpPWpGaD
Methyl aminolevulinate—Eye disorder—Dexamethasone—ulcerative colitis	0.00111	0.00222	CcSEcCtD
Methyl aminolevulinate—Eye disorder—Betamethasone—ulcerative colitis	0.00111	0.00222	CcSEcCtD
Methyl aminolevulinate—Urticaria—Mesalazine—ulcerative colitis	0.0011	0.0022	CcSEcCtD
Methyl aminolevulinate—Rash—Budesonide—ulcerative colitis	0.00107	0.00215	CcSEcCtD
Methyl aminolevulinate—Dermatitis—Budesonide—ulcerative colitis	0.00107	0.00215	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Immune System—NOD2—ulcerative colitis	0.00107	0.00214	CbGpPWpGaD
Methyl aminolevulinate—Headache—Budesonide—ulcerative colitis	0.00107	0.00214	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Immune System—CD14—ulcerative colitis	0.00107	0.00213	CbGpPWpGaD
Methyl aminolevulinate—Discomfort—Prednisolone—ulcerative colitis	0.00104	0.00208	CcSEcCtD
Methyl aminolevulinate—Erythema—Dexamethasone—ulcerative colitis	0.00103	0.00207	CcSEcCtD
Methyl aminolevulinate—Erythema—Betamethasone—ulcerative colitis	0.00103	0.00207	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Immune System—VCAM1—ulcerative colitis	0.00103	0.00206	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—HLA-DQA1—ulcerative colitis	0.00103	0.00205	CbGpPWpGaD
Methyl aminolevulinate—Hypersensitivity—Mesalazine—ulcerative colitis	0.00102	0.00204	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—CDH1—ulcerative colitis	0.00102	0.00204	CbGpPWpGaD
Methyl aminolevulinate—Discomfort—Hydrocortisone—ulcerative colitis	0.00102	0.00203	CcSEcCtD
Methyl aminolevulinate—Nausea—Budesonide—ulcerative colitis	0.00101	0.00203	CcSEcCtD
Methyl aminolevulinate—Oedema—Prednisolone—ulcerative colitis	0.00101	0.00202	CcSEcCtD
Methyl aminolevulinate—Dizziness—Azathioprine—ulcerative colitis	0.00101	0.00201	CcSEcCtD
Methyl aminolevulinate—Asthenia—Mesalazine—ulcerative colitis	0.000995	0.00199	CcSEcCtD
Methyl aminolevulinate—Oedema—Hydrocortisone—ulcerative colitis	0.000986	0.00197	CcSEcCtD
Methyl aminolevulinate—Pruritus—Mesalazine—ulcerative colitis	0.000981	0.00196	CcSEcCtD
Methyl aminolevulinate—Infection—Hydrocortisone—ulcerative colitis	0.00098	0.00196	CcSEcCtD
Methyl aminolevulinate—Eye disorder—Prednisone—ulcerative colitis	0.000965	0.00193	CcSEcCtD
Methyl aminolevulinate—Rash—Azathioprine—ulcerative colitis	0.00096	0.00192	CcSEcCtD
Methyl aminolevulinate—Dermatitis—Azathioprine—ulcerative colitis	0.000959	0.00192	CcSEcCtD
Methyl aminolevulinate—Discomfort—Triamcinolone—ulcerative colitis	0.000957	0.00191	CcSEcCtD
Methyl aminolevulinate—Discomfort—Methylprednisolone—ulcerative colitis	0.000955	0.00191	CcSEcCtD
Methyl aminolevulinate—Headache—Azathioprine—ulcerative colitis	0.000954	0.00191	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Innate Immune System—JAK2—ulcerative colitis	0.000932	0.00186	CbGpPWpGaD
Methyl aminolevulinate—Oedema—Triamcinolone—ulcerative colitis	0.000928	0.00186	CcSEcCtD
Methyl aminolevulinate—Infection—Triamcinolone—ulcerative colitis	0.000922	0.00185	CcSEcCtD
Methyl aminolevulinate—Infection—Methylprednisolone—ulcerative colitis	0.00092	0.00184	CcSEcCtD
Methyl aminolevulinate—Dizziness—Mesalazine—ulcerative colitis	0.000917	0.00183	CcSEcCtD
Methyl aminolevulinate—Paraesthesia—Prednisolone—ulcerative colitis	0.000907	0.00181	CcSEcCtD
Methyl aminolevulinate—Nausea—Azathioprine—ulcerative colitis	0.000904	0.00181	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Innate Immune System—RELA—ulcerative colitis	0.000903	0.0018	CbGpPWpGaD
Methyl aminolevulinate—Erythema—Prednisone—ulcerative colitis	0.000899	0.0018	CcSEcCtD
Methyl aminolevulinate—Paraesthesia—Hydrocortisone—ulcerative colitis	0.000885	0.00177	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Innate Immune System—CD4—ulcerative colitis	0.000884	0.00177	CbGpPWpGaD
Methyl aminolevulinate—Rash—Mesalazine—ulcerative colitis	0.000874	0.00175	CcSEcCtD
Methyl aminolevulinate—Dermatitis—Mesalazine—ulcerative colitis	0.000873	0.00175	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Immune System—ADCY5—ulcerative colitis	0.000871	0.00174	CbGpPWpGaD
Methyl aminolevulinate—Headache—Mesalazine—ulcerative colitis	0.000869	0.00174	CcSEcCtD
Methyl aminolevulinate—Discomfort—Dexamethasone—ulcerative colitis	0.000868	0.00174	CcSEcCtD
Methyl aminolevulinate—Discomfort—Betamethasone—ulcerative colitis	0.000868	0.00174	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—RELA—ulcerative colitis	0.000867	0.00173	CbGpPWpGaD
Methyl aminolevulinate—Pain—Prednisolone—ulcerative colitis	0.000863	0.00173	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Cytokine Signaling in Immune system—IL6—ulcerative colitis	0.000852	0.0017	CbGpPWpGaD
Methyl aminolevulinate—Fatigue—Hydrocortisone—ulcerative colitis	0.00085	0.0017	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—CD4—ulcerative colitis	0.000849	0.0017	CbGpPWpGaD
Methyl aminolevulinate—Pain—Hydrocortisone—ulcerative colitis	0.000843	0.00169	CcSEcCtD
Methyl aminolevulinate—Oedema—Dexamethasone—ulcerative colitis	0.000842	0.00169	CcSEcCtD
Methyl aminolevulinate—Oedema—Betamethasone—ulcerative colitis	0.000842	0.00169	CcSEcCtD
Methyl aminolevulinate—Infection—Dexamethasone—ulcerative colitis	0.000837	0.00167	CcSEcCtD
Methyl aminolevulinate—Infection—Betamethasone—ulcerative colitis	0.000837	0.00167	CcSEcCtD
Methyl aminolevulinate—Paraesthesia—Triamcinolone—ulcerative colitis	0.000834	0.00167	CcSEcCtD
Methyl aminolevulinate—Paraesthesia—Methylprednisolone—ulcerative colitis	0.000832	0.00166	CcSEcCtD
Methyl aminolevulinate—Nausea—Mesalazine—ulcerative colitis	0.000824	0.00165	CcSEcCtD
Methyl aminolevulinate—Urticaria—Prednisolone—ulcerative colitis	0.000802	0.0016	CcSEcCtD
Methyl aminolevulinate—Fatigue—Triamcinolone—ulcerative colitis	0.0008	0.0016	CcSEcCtD
Methyl aminolevulinate—Fatigue—Methylprednisolone—ulcerative colitis	0.000799	0.0016	CcSEcCtD
Methyl aminolevulinate—Pain—Triamcinolone—ulcerative colitis	0.000794	0.00159	CcSEcCtD
Methyl aminolevulinate—Urticaria—Hydrocortisone—ulcerative colitis	0.000783	0.00157	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Immune System—CRP—ulcerative colitis	0.000762	0.00152	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Innate Immune System—NFKB1—ulcerative colitis	0.000761	0.00152	CbGpPWpGaD
Methyl aminolevulinate—Paraesthesia—Betamethasone—ulcerative colitis	0.000756	0.00151	CcSEcCtD
Methyl aminolevulinate—Paraesthesia—Dexamethasone—ulcerative colitis	0.000756	0.00151	CcSEcCtD
Methyl aminolevulinate—Discomfort—Prednisone—ulcerative colitis	0.000756	0.00151	CcSEcCtD
Methyl aminolevulinate—Hypersensitivity—Prednisolone—ulcerative colitis	0.000744	0.00149	CcSEcCtD
Methyl aminolevulinate—Urticaria—Triamcinolone—ulcerative colitis	0.000738	0.00148	CcSEcCtD
Methyl aminolevulinate—Urticaria—Methylprednisolone—ulcerative colitis	0.000736	0.00147	CcSEcCtD
Methyl aminolevulinate—Oedema—Prednisone—ulcerative colitis	0.000734	0.00147	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—NFKB1—ulcerative colitis	0.000731	0.00146	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—TLR4—ulcerative colitis	0.000731	0.00146	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—HLA-DRB1—ulcerative colitis	0.00073	0.00146	CbGpPWpGaD
Methyl aminolevulinate—Infection—Prednisone—ulcerative colitis	0.000729	0.00146	CcSEcCtD
Methyl aminolevulinate—Hypersensitivity—Hydrocortisone—ulcerative colitis	0.000726	0.00145	CcSEcCtD
Methyl aminolevulinate—Fatigue—Dexamethasone—ulcerative colitis	0.000726	0.00145	CcSEcCtD
Methyl aminolevulinate—Fatigue—Betamethasone—ulcerative colitis	0.000726	0.00145	CcSEcCtD
Methyl aminolevulinate—Pain—Dexamethasone—ulcerative colitis	0.00072	0.00144	CcSEcCtD
Methyl aminolevulinate—Pain—Betamethasone—ulcerative colitis	0.00072	0.00144	CcSEcCtD
Methyl aminolevulinate—Asthenia—Hydrocortisone—ulcerative colitis	0.000707	0.00142	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Immune System—ICAM1—ulcerative colitis	0.0007	0.0014	CbGpPWpGaD
Methyl aminolevulinate—Pruritus—Hydrocortisone—ulcerative colitis	0.000698	0.0014	CcSEcCtD
Methyl aminolevulinate—Hypersensitivity—Triamcinolone—ulcerative colitis	0.000684	0.00137	CcSEcCtD
Methyl aminolevulinate—Hypersensitivity—Methylprednisolone—ulcerative colitis	0.000682	0.00137	CcSEcCtD
Methyl aminolevulinate—Urticaria—Betamethasone—ulcerative colitis	0.000669	0.00134	CcSEcCtD
Methyl aminolevulinate—Urticaria—Dexamethasone—ulcerative colitis	0.000669	0.00134	CcSEcCtD
Methyl aminolevulinate—Dizziness—Prednisolone—ulcerative colitis	0.000668	0.00134	CcSEcCtD
Methyl aminolevulinate—Asthenia—Triamcinolone—ulcerative colitis	0.000666	0.00133	CcSEcCtD
Methyl aminolevulinate—Asthenia—Methylprednisolone—ulcerative colitis	0.000665	0.00133	CcSEcCtD
Methyl aminolevulinate—Paraesthesia—Prednisone—ulcerative colitis	0.000659	0.00132	CcSEcCtD
Methyl aminolevulinate—Pruritus—Triamcinolone—ulcerative colitis	0.000657	0.00131	CcSEcCtD
Methyl aminolevulinate—Pruritus—Methylprednisolone—ulcerative colitis	0.000655	0.00131	CcSEcCtD
Methyl aminolevulinate—Dizziness—Hydrocortisone—ulcerative colitis	0.000652	0.0013	CcSEcCtD
Methyl aminolevulinate—Rash—Prednisolone—ulcerative colitis	0.000637	0.00127	CcSEcCtD
Methyl aminolevulinate—Dermatitis—Prednisolone—ulcerative colitis	0.000636	0.00127	CcSEcCtD
Methyl aminolevulinate—Fatigue—Prednisone—ulcerative colitis	0.000632	0.00127	CcSEcCtD
Methyl aminolevulinate—Headache—Prednisolone—ulcerative colitis	0.000632	0.00127	CcSEcCtD
Methyl aminolevulinate—Rash—Hydrocortisone—ulcerative colitis	0.000622	0.00124	CcSEcCtD
Methyl aminolevulinate—Dermatitis—Hydrocortisone—ulcerative colitis	0.000621	0.00124	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Immune System—CDH1—ulcerative colitis	0.000619	0.00124	CbGpPWpGaD
Methyl aminolevulinate—Headache—Hydrocortisone—ulcerative colitis	0.000618	0.00124	CcSEcCtD
Methyl aminolevulinate—Dizziness—Triamcinolone—ulcerative colitis	0.000614	0.00123	CcSEcCtD
Methyl aminolevulinate—Dizziness—Methylprednisolone—ulcerative colitis	0.000613	0.00123	CcSEcCtD
Methyl aminolevulinate—Asthenia—Dexamethasone—ulcerative colitis	0.000604	0.00121	CcSEcCtD
Methyl aminolevulinate—Asthenia—Betamethasone—ulcerative colitis	0.000604	0.00121	CcSEcCtD
Methyl aminolevulinate—Nausea—Prednisolone—ulcerative colitis	0.0006	0.0012	CcSEcCtD
Methyl aminolevulinate—Pruritus—Dexamethasone—ulcerative colitis	0.000596	0.00119	CcSEcCtD
Methyl aminolevulinate—Pruritus—Betamethasone—ulcerative colitis	0.000596	0.00119	CcSEcCtD
Methyl aminolevulinate—Nausea—Hydrocortisone—ulcerative colitis	0.000586	0.00117	CcSEcCtD
Methyl aminolevulinate—Rash—Triamcinolone—ulcerative colitis	0.000585	0.00117	CcSEcCtD
Methyl aminolevulinate—Dermatitis—Triamcinolone—ulcerative colitis	0.000585	0.00117	CcSEcCtD
Methyl aminolevulinate—Rash—Methylprednisolone—ulcerative colitis	0.000584	0.00117	CcSEcCtD
Methyl aminolevulinate—Dermatitis—Methylprednisolone—ulcerative colitis	0.000584	0.00117	CcSEcCtD
Methyl aminolevulinate—Urticaria—Prednisone—ulcerative colitis	0.000583	0.00117	CcSEcCtD
Methyl aminolevulinate—Headache—Triamcinolone—ulcerative colitis	0.000582	0.00116	CcSEcCtD
Methyl aminolevulinate—Headache—Methylprednisolone—ulcerative colitis	0.00058	0.00116	CcSEcCtD
Methyl aminolevulinate—Dizziness—Betamethasone—ulcerative colitis	0.000557	0.00111	CcSEcCtD
Methyl aminolevulinate—Dizziness—Dexamethasone—ulcerative colitis	0.000557	0.00111	CcSEcCtD
Methyl aminolevulinate—Nausea—Triamcinolone—ulcerative colitis	0.000551	0.0011	CcSEcCtD
Methyl aminolevulinate—Nausea—Methylprednisolone—ulcerative colitis	0.00055	0.0011	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Immune System—JAK2—ulcerative colitis	0.000543	0.00109	CbGpPWpGaD
Methyl aminolevulinate—Hypersensitivity—Prednisone—ulcerative colitis	0.00054	0.00108	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Immune System—IFNG—ulcerative colitis	0.000533	0.00107	CbGpPWpGaD
Methyl aminolevulinate—Rash—Dexamethasone—ulcerative colitis	0.000531	0.00106	CcSEcCtD
Methyl aminolevulinate—Rash—Betamethasone—ulcerative colitis	0.000531	0.00106	CcSEcCtD
Methyl aminolevulinate—Dermatitis—Betamethasone—ulcerative colitis	0.000531	0.00106	CcSEcCtD
Methyl aminolevulinate—Dermatitis—Dexamethasone—ulcerative colitis	0.000531	0.00106	CcSEcCtD
Methyl aminolevulinate—Headache—Dexamethasone—ulcerative colitis	0.000528	0.00106	CcSEcCtD
Methyl aminolevulinate—Headache—Betamethasone—ulcerative colitis	0.000528	0.00106	CcSEcCtD
Methyl aminolevulinate—Asthenia—Prednisone—ulcerative colitis	0.000526	0.00105	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Immune System—RELA—ulcerative colitis	0.000526	0.00105	CbGpPWpGaD
Methyl aminolevulinate—Pruritus—Prednisone—ulcerative colitis	0.000519	0.00104	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Immune System—CD4—ulcerative colitis	0.000515	0.00103	CbGpPWpGaD
Methyl aminolevulinate—Nausea—Dexamethasone—ulcerative colitis	0.0005	0.001	CcSEcCtD
Methyl aminolevulinate—Nausea—Betamethasone—ulcerative colitis	0.0005	0.001	CcSEcCtD
Methyl aminolevulinate—Dizziness—Prednisone—ulcerative colitis	0.000485	0.000971	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Innate Immune System—IL6—ulcerative colitis	0.000478	0.000955	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—IL1B—ulcerative colitis	0.000475	0.00095	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—IL2—ulcerative colitis	0.000474	0.000947	CbGpPWpGaD
Methyl aminolevulinate—Rash—Prednisone—ulcerative colitis	0.000463	0.000926	CcSEcCtD
Methyl aminolevulinate—Dermatitis—Prednisone—ulcerative colitis	0.000462	0.000925	CcSEcCtD
Methyl aminolevulinate—Headache—Prednisone—ulcerative colitis	0.00046	0.00092	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Immune System—NFKB1—ulcerative colitis	0.000443	0.000886	CbGpPWpGaD
Methyl aminolevulinate—Nausea—Prednisone—ulcerative colitis	0.000436	0.000872	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Immune System—STAT3—ulcerative colitis	0.000398	0.000796	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—IL6—ulcerative colitis	0.000278	0.000556	CbGpPWpGaD
